Explore more publications!

Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on March 16, 2026

Sovereign Silver Confirms Full Compliance with Health Canada’s Landmark Carbomer Safety Update
Ritaann's Ride for Veterans with Brain Injury
FacialDx Invites Professional and Youth Sports Organizations to Pilot Athlete Recovery and Health Monitoring Platform
MedBetterHealth, Integrated Specialty Alliance, and Design Neuroscience Center Form Strategic Dementia Care Alliance
Agape Treatment Center Announces In-Network Partnership with Cigna Insurance Across All Locations
Austin Natural Mattress Celebrates 26 Years as Central Texas Leader in Organic and Non-Toxic Sleep Products
Pattern Discovers New microRNA Drug for Treatment of Glioblastoma Cancer
Pennant Group to Participate in the 2026 Oppenheimer Annual Healthcare Conference
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
HEALTHCRED Names Former Florida Deputy Secretary  Steve Casey As EVP OF Government & Strategic  Partnerships
Imprivata Introduces New Advanced Access Management and Passwordless Authentication Capabilities to Enhance Clinical Efficiency, Security, and Essential Eight Compliance
CMR Surgical Advances Physical AI to Support the Future of Robotic Surgery with NVIDIA
iBio to Provide an Update on Cardiopulmonary Program Targeting Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
LENSAR® Announces Termination of Merger Agreement with Alcon Research, LLC
HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock
Perspective Therapeutics Provides Recent Business Highlights and Reports Full Year 2025 Results
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
Cue Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions